World's Best Scientists 2026 revealed!
VIEW LIST
Myron S. Czuczman

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 83 15455 14539 7795 7212 423 30828

Myron S. Czuczman publications per year

The chart shows the history of publications by Myron S. Czuczman between 1982 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Myron S. Czuczman published across 44 years, from 1982 to 2025, averaging 11.1 papers a year. Output peaked at 67 publications in 2023. 2 of the 490 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1982 to 2025. Vertical axis: number of publications, 0 to 67. Peak 67 publications in 2023. 1982: 2 publications 1983: 0 publications 1984: 1 publication 1985: 0 publications 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 4 publications 1994: 1 publication 1995: 0 publications 1996: 0 publications 1997: 2 publications 1998: 3 publications 1999: 6 publications 2000: 8 publications 2001: 9 publications 2002: 10 publications 2003: 6 publications 2004: 30 publications 2005: 24 publications 2006: 22 publications 2007: 23 publications 2008: 27 publications 2009: 32 publications 2010: 43 publications 2011: 18 publications 2012: 33 publications 2013: 30 publications 2014: 21 publications 2015: 30 publications 2016: 5 publications 2017: 4 publications 2018: 2 publications 2019: 16 publications 2020: 2 publications 2021: 3 publications 2022: 4 publications 2023: 67 publications 2024: 1 publication 2025: 1 publication
1982 2025

490 publications in total across all disciplines

View publications per year as a table
Myron S. Czuczman: publications per year, 1982 to 2025
Year Publications
1982 2
1983 0
1984 1
1985 0
1986 0
1987 0
1988 0
1989 0
1990 0
1991 0
1992 0
1993 4
1994 1
1995 0
1996 0
1997 2
1998 3
1999 6
2000 8
2001 9
2002 10
2003 6
2004 30
2005 24
2006 22
2007 23
2008 27
2009 32
2010 43
2011 18
2012 33
2013 30
2014 21
2015 30
2016 5
2017 4
2018 2
2019 16
2020 2
2021 3
2022 4
2023 67
2024 1
2025 1
Total 490
Download as CSV

Myron S. Czuczman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Myron S. Czuczman sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 421–440 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 423 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806 423
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Myron S. Czuczman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Myron S. Czuczman sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 82–83 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027 83
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Myron S. Czuczman is affiliated with Citius Pharmaceuticals, Inc. in the United States. Their research primarily focuses on oncology, with a total of 29 publications in the field of medicine. Within oncology, key subfields of study include pathology and forensic medicine, genetics, immunology, and dermatology.

The scientist's work covers several main topics, including:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • Cutaneous lymphoproliferative disorders research
  • Toxin Mechanisms and Immunotoxins
  • Cancer Immunotherapy and Biomarkers
  • Viral-associated cancers and disorders

Recent publications authored or co-authored by Myron S. Czuczman include:

  • ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma, 2021, Journal of Clinical Oncology
  • Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy, 2020, The American Journal of Surgical Pathology
  • Efficacy and Safety of E7777 (improved purity Denileukin diftitox [ONTAK]) in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma: Results from Pivotal Study 302, 2022, Blood
  • Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma, 2024, Journal of Clinical Oncology
  • Targeting regulatory T cells by E7777 enhances CD8 T-cell-mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models, 2023, Frontiers in Immunology

Publication venues frequently associated with Myron S. Czuczman's work include:

  • Blood
  • Journal of Clinical Oncology
  • Frontiers in Immunology
  • The American Journal of Surgical Pathology
  • Cancer Reports

Frequent co-authors collaborating with Myron S. Czuczman are:

  • Chean Eng Ooi
  • Dongyuan Xing
  • Nicholas Sauter
  • Preeti Singh
  • Thomas E. Witzig

Best Publications

  • Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

    P McLaughlin;A J Grillo-López;B K Link;R Levy

  • Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma

    Thomas E. Witzig;Leo I. Gordon;Fernando Cabanillas;Myron S. Czuczman

  • Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy

    Myron S. Czuczman;A. J. Grillo-López;C. A. White;M. Saleh

  • Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

    Wyndham H Wilson;Owen A O'Connor;Myron S Czuczman;Ann S LaCasce

  • An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

    Zheng Zhou;Laurie H. Sehn;Alfred W. Rademaker;Leo I. Gordon

  • Treatment With Ibritumomab Tiuxetan Radioimmunotherapy in Patients With Rituximab-Refractory Follicular Non-Hodgkin’s Lymphoma

    Thomas E. Witzig;Ian W. Flinn;Leo I. Gordon;Christos Emmanouilides

  • Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment

    Thomas A. Davis;Antonio J. Grillo-López;Christine A. White;Peter McLaughlin

  • Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

    Kieron Dunleavy;Stefania Pittaluga;Myron S. Czuczman;Sandeep S. Dave

  • Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma

    N. L. Berinstein;A. J. Grillo-Lopez;C. A. White;I. Bence-Bruckler

  • Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma

    J. M. Vose;B. K. Link;M. L. Grossbard;M. Czuczman

  • Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma

    L. D. Piro;C. A. White;A. J. Grillo-López;N. Janakiraman

  • Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study

    Asher Chanan-Khan;Kena C. Miller;Laurie Musial;David Lawrence

  • Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.

    Myron S. Czuczman;Robin Weaver;Baha Alkuzweny;Judy Berlfein

  • An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma

    T. E. Witzig;Julie Marie Vose;P. L. Zinzani;C. B. Reeder

  • Non-Hodgkin's Lymphomas

    Andrew D. Zelenetz;Ranjana H. Advani;John C. Byrd;Myron S. Czuczman

  • Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study

    Anjali Advani;Bertrand Coiffier;Myron S. Czuczman;Martin Dreyling

  • NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.

    Zelenetz Ad;Abramson Js;Advani Rh;Andreadis Cb

  • Use of rituximab, the new FDA-approved antibody

    Gail A. Leget;Myron S. Czuczman

  • Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study

    Maria Corinna A Palanca-Wessels;Myron Czuczman;Gilles Salles;Sarit Assouline

  • Rituximab A nti-CD20 M onoclonal A ntibody T herapy i n Non-Hodgkin's L ymphoma: S afety a nd E fficacy o f Re-Treatment

    Thomas A. Davis;Christine A. White;Peter McLaughlin;Myron S. Czuczman

Frequent Co-Authors

Leo I. Gordon
Leo I. Gordon Northwestern University
Andrew D. Zelenetz
Andrew D. Zelenetz Memorial Sloan Kettering Cancer Center
Jonathan W. Friedberg
Jonathan W. Friedberg University of Rochester
John P. Leonard
John P. Leonard Cornell University
Thomas E. Witzig
Thomas E. Witzig Mayo Clinic
Luis Fayad
Luis Fayad The University of Texas MD Anderson Cancer Center
Bruce D. Cheson
Bruce D. Cheson Georgetown University
Julie M. Vose
Julie M. Vose University of Nebraska Medical Center
Nancy L. Bartlett
Nancy L. Bartlett Washington University in St. Louis
Oliver W. Press
Oliver W. Press University of Washington

External Links

Personal website of Myron S. Czuczman

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a medical career but aren’t ready to commit to a full MD program, there are valuable alternatives worth exploring. Aspiring nurses might consider adn programs, which offer a quicker path to becoming a registered nurse and are often more accessible in terms of admissions requirements.

For those interested in the administrative side of healthcare, pursuing a health care administration degree online can open doors to management roles in hospitals, clinics, and healthcare organizations—often with flexible, accelerated learning formats.

Entry requirements vary across fields. Prospective Licensed Practical Nurses (LPNs) may wonder, do I need to take the teas test for lpn? The answer depends on the program, with some schools waiving standardized test requirements.

Finally, support roles like medical coding are in high demand. You can start this career by taking online medical coding classes with financial aid, making it accessible to students from various backgrounds.

Best Scientists Citing Myron S. Czuczman

Gilles Salles

Gilles Salles

Memorial Sloan Kettering Cancer Center

Publications: 104

John P. Leonard

John P. Leonard

Cornell University

Publications: 101

Oliver W. Press

Oliver W. Press

University of Washington

Publications: 101

Pier Luigi Zinzani

Pier Luigi Zinzani

University of Bologna

Publications: 96

Jonathan W. Friedberg

Jonathan W. Friedberg

University of Rochester

Publications: 94

Martin Dreyling

Martin Dreyling

Ludwig-Maximilians-Universität München

Publications: 92

David M. Goldenberg

David M. Goldenberg

Immunomedics (United States)

Publications: 84

Bruce D. Cheson

Bruce D. Cheson

Georgetown University

Publications: 80

Christopher R. Flowers

Christopher R. Flowers

The University of Texas MD Anderson Cancer Center

Publications: 76

John F. Seymour

John F. Seymour

Peter MacCallum Cancer Centre

Publications: 76

Susan O'Brien

Susan O'Brien

University of California, Irvine

Publications: 76

Thomas E. Witzig

Thomas E. Witzig

Mayo Clinic

Publications: 75

John C. Byrd

John C. Byrd

University of Pittsburgh Cancer Institute

Publications: 74

Bertrand Coiffier

Bertrand Coiffier

Centre Hospitalier Lyon Sud

Publications: 64

Stephen M. Ansell

Stephen M. Ansell

Mayo Clinic

Publications: 63

Thomas M. Habermann

Thomas M. Habermann

Mayo Clinic

Publications: 59

Trending Scientists

Roderic S. Lakes

Roderic S. Lakes

University of Wisconsin–Madison

Lianbo Ma

Lianbo Ma

Anhui University of Technology

Pedro J. Aphalo

Pedro J. Aphalo

University of Helsinki

Robert J. Ursano

Robert J. Ursano

Uniformed Services University of the Health Sciences

Jes Vollertsen

Jes Vollertsen

Aalborg University

Brian Berkowitz

Brian Berkowitz

Weizmann Institute of Science

James S. Famiglietti

James S. Famiglietti

University of Saskatchewan

Kenneth Richards

Kenneth Richards

Centre national de la recherche scientifique, CNRS

Bechara Kachar

Bechara Kachar

National Institutes of Health

Dario Leister

Dario Leister

Ludwig-Maximilians-Universität München

Gerhard Opelz

Gerhard Opelz

Heidelberg University

William Buxton

William Buxton

Microsoft (United States)

Junichiro Yamaguchi

Junichiro Yamaguchi

Waseda University

John F. Helliwell

John F. Helliwell

University of British Columbia

Jeremy M. Grimshaw

Jeremy M. Grimshaw

Ottawa Hospital

Cary P. Gross

Cary P. Gross

Yale University

Related Medicine Rankings & Guides

2027 Best Online MSN in Health/Nursing Informatics Programs

2027 Best Online MSN in Health/Nursing Informatics Programs
2027 Fastest Online MSN in Nursing Education Programs

2027 Fastest Online MSN in Nursing Education Programs
2027 How Fast Can I Finish an RN to BSN

2027 How Fast Can I Finish an RN to BSN
2027 Best Second-Degree BSN Programs

2027 Best Second-Degree BSN Programs
2027 Fastest Online Master's Degree in Healthcare Management Programs

2027 Fastest Online Master's Degree in Healthcare Management Programs
2027 Is Nursing School Worth It?

2027 Is Nursing School Worth It?
2027 Fastest Online Adult-Gerontology PCNP Graduate Certificate Programs

2027 Fastest Online Adult-Gerontology PCNP Graduate Certificate Programs
2027 Easiest Medical Degree Programs

2027 Easiest Medical Degree Programs
2027 Most Affordable Online MSN in Nurse Executive Leadership Programs

2027 Most Affordable Online MSN in Nurse Executive Leadership Programs
2027 Best One-Year Online PMHNP Programs

2027 Best One-Year Online PMHNP Programs
2027 Fastest Online Graduate Certificate Nurse Midwifery Programs

2027 Fastest Online Graduate Certificate Nurse Midwifery Programs
2026 Easiest Accelerated BSN Programs to Get Into

2026 Easiest Accelerated BSN Programs to Get Into
September 2027 Best Online Physician Assistant Master’s Programs

September 2027 Best Online Physician Assistant Master’s Programs
2027 Fastest Doctor of Nursing Practice (DNP) Degree Programs

2027 Fastest Doctor of Nursing Practice (DNP) Degree Programs
2027 Best Online BSN to FNP Programs

2027 Best Online BSN to FNP Programs
2027 Most Affordable Online AGNP Programs

2027 Most Affordable Online AGNP Programs
2027 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities

2027 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities
2027 Most Affordable Online FNP Programs

2027 Most Affordable Online FNP Programs
2027 Best Online Nursing Programs in Iowa – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Iowa – Accredited RN to BSN Programs
2027 Most Affordable Online Associate’s Degree in Radiology

2027 Most Affordable Online Associate’s Degree in Radiology
September 2027 Best Online Certificate Program in Medical Office Administration: Guide to Online Degrees

September 2027 Best Online Certificate Program in Medical Office Administration: Guide to Online Degrees

Recently Published Articles

2027 Hardest and Easiest Courses in a Political Science Degree Program

2027 Hardest and Easiest Courses in a Political Science Degree Program
2027 Substitute Teaching License & Requirements in Delaware

2027 Substitute Teaching License & Requirements in Delaware
2027 What Requirements Do You Need for an Online Neuroscience Bachelor's Degree? Admission Rules, Credits & Eligibility

2027 What Requirements Do You Need for an Online Neuroscience Bachelor's Degree? Admission Rules, Credits & Eligibility
2027 GPA, Test Scores, and Experience Needed for Fashion Design Degree Programs

2027 GPA, Test Scores, and Experience Needed for Fashion Design Degree Programs
2027 Online Game Programming & Development Bachelor's Degree Completion Programs for Working Adults

2027 Online Game Programming & Development Bachelor's Degree Completion Programs for Working Adults
2027 Political Science Degree Salary by Experience Level: Entry-Level, Mid-Career, and Senior Roles

2027 Political Science Degree Salary by Experience Level: Entry-Level, Mid-Career, and Senior Roles
2027 Early Childhood Education Degree Coursework Explained: What Classes Can You Expect to Take?

2027 Early Childhood Education Degree Coursework Explained: What Classes Can You Expect to Take?
2027 Best Online Fine Arts Degree Master's Programs for Working Professionals

2027 Best Online Fine Arts Degree Master's Programs for Working Professionals
2027 Best Career Pivot Options for People With a Behavioral Health Degree

2027 Best Career Pivot Options for People With a Behavioral Health Degree
2027 Best Online Nursing Programs in Utah: Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Utah: Accredited RN to BSN Programs
2027 Best BSN to MSN Programs in Ohio: Online & Campus

2027 Best BSN to MSN Programs in Ohio: Online & Campus
2027 Self-Paced Online Management Information Systems Bachelor's Degree Programs

2027 Self-Paced Online Management Information Systems Bachelor's Degree Programs
2027 Ways to Go from a Medical Assistant to a Registered Nurse (MA to RN)

2027 Ways to Go from a Medical Assistant to a Registered Nurse (MA to RN)
2027 How to Become a Preschool Teacher Assistant in Utah: Requirements & Certification

2027 How to Become a Preschool Teacher Assistant in Utah: Requirements & Certification
2027 Can You Get Into a Fine Arts Program with a Low GPA? Admission Chances & Workarounds

2027 Can You Get Into a Fine Arts Program with a Low GPA? Admission Chances & Workarounds
2027 Can You Get Into a School Counseling Degree Master's Program with a Low GPA? Admission Chances & Workarounds

2027 Can You Get Into a School Counseling Degree Master's Program with a Low GPA? Admission Chances & Workarounds
2027 Online Interior Design Bachelor's Degree Programs With 8-Week Classes

2027 Online Interior Design Bachelor's Degree Programs With 8-Week Classes
2027 Remote Jobs You Can Get With a Nursing Education Master's Degree

2027 Remote Jobs You Can Get With a Nursing Education Master's Degree
2027 How Fast Can You Earn an Online Health Administration Master's Degree? Timelines & Completion Options

2027 How Fast Can You Earn an Online Health Administration Master's Degree? Timelines & Completion Options
2027 Florida Nursing License Requirements

2027 Florida Nursing License Requirements
2027 Easy Certifications That Pay Well

2027 Easy Certifications That Pay Well